Ribosomal dysfunction-activated ERK1/2 was notably attenuated by PRDM1 depletion via its shRNA, indicating the positive regulation of ERK1/2-linked signaling pathways by PRDM1 in response to ribosomal dysfunction in cancer cells (Fig. 5d). The gene discussed is MAPK3; the disease is cancer.